Xenon Pharmaceuticals Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 1, 2017, details the results of Xenon Pharmaceuticals Inc.'s 2017 Annual Meeting of Shareholders. The meeting was held on June 1, 2017, with approximately 62.5% of total shares entitled to vote present via proxy or in person.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and shareholder voting results.
Material Changes and Voting Results
Three proposals were voted upon at the Annual Meeting:
- Proposal One (Election of Directors): All nine nominees were elected to serve until the 2018 annual meeting. Richard Scheller received the highest number of "For" votes (8,869,381), while Michael Hayden received the lowest (7,664,472). All nominees received significant support, with "Withhold" votes ranging from approximately 426,508 to 1,631,417.
- Proposal Two (Appointment of Auditor): The appointment of KPMG LLP as the independent registered public accounting firm was approved with 10,987,565 votes "For" and 263,912 votes "Withhold".
- Proposal Three (Auditor Remuneration): The authorization for the Audit Committee to set auditor remuneration was approved with 10,956,971 votes "For" and 294,506 votes "Against".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to report the submission of matters to a vote of security holders.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 27, 2017, for detailed biographies of the elected directors and the rationale for the auditor appointment.
- Confirm the total number of outstanding shares to contextualize the 11,251,477 shares voted.
- Review subsequent filings for the official appointment of KPMG LLP and the commencement of their audit for the ensuing year.